Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Parenteral Iron and EPO in Preterm Infants
NCT02060851Phase 4Completed
- Sponsor
- The First People's Hospital of Kunshan
- Start
- Feb 2014
- Primary completion
- Jun 2014
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of iron sucrose and erythropoietin in anemia of prematurity (AOP) (3 arms), sponsored by The First People's Hospital of Kunshan. Primary endpoint: Hematological evaluation up to 2 weeks. Started Feb 2014; status: completed.
02
Drugs
iron sucroseerythropoietin
03
Conditions
anemia of prematurity (AOP)
Beyond the preview
Go deeper on NCT02060851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02060851.